Massimo Ganassi

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Herpes Simplex Virus

Duchenne Muscular Dystrophy

Top Venues

Cancer gene therapy

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew V Cowley, Johanna Pruller, Massimo Ganassi, Peter S Zammit, Christopher R S Banerji
An in silico FSHD muscle fibre for modelling DUX4 dynamics and predicting the impact of therapy. eLife 12 (2023)
Johanna Pruller, Isabella Hofer, Massimo Ganassi, Philipp Heher, Michelle T Ma, Peter S Zammit
A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy. Cancer gene therapy 28 (5) (2020)
Johanna Pruller, Isabella Hofer, Massimo Ganassi, Philipp Heher, Michelle T Ma, Peter S Zammit
Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy. Cancer gene therapy (2020)
Massimo Ganassi, Sara Badodi, Kees Wanders, Peter S Zammit, Simon M Hughes
Myogenin is an essential regulator of adult myofibre growth and muscle stem cell homeostasis. eLife 9 (2020)
Massimo Ganassi, Sara Badodi, Huascar Pedro Ortuste Quiroga, Peter S Zammit, Yaniv Hinits, Simon M Hughes
Myogenin promotes myocyte fusion to balance fibre number and size. Nature communications 9 (1) (2018)